Korea Pharmaceutical and Bio-Pharma Manufacturers Association Vows to Minimize Industry Impact from Government Drug Price Cuts

Korea Pharmaceutical and Bio-Pharma Manufacturers Association holds emergency meeting to address government's drug price reform, which cuts generic pricing rate from 53.55% to 45%, with gradual implementation until 2036 to minimize industry impact

Rx Inspector: ProPublica’s New Tool Provides Drug Info the FDA Won’t

We’ve launched a first-of-its-kind app to help you find out where your generic drugs come from and see the track records of the factories that made them.

ProPublica: ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs

ProPublica: ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs. “The data, which ProPublica created by linking several FDA datasets, has never been made availab…

The FDA’s Lax Generic Drug Rules Can Put Patients’ Lives at Risk – The USA Potato

The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, So ProPublica Did

Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every year, its own records show, and it has largely dismissed warnings about contaminants, irregularities and other issues.